Selected article for: "high dose group and low dose"

Author: Lan, Jiaming; Yao, Yanfeng; Deng, Yao; Chen, Hong; Lu, Guangwen; Wang, Wen; Bao, Linlin; Deng, Wei; Wei, Qiang; Gao, George F.; Qin, Chuan; Tan, Wenjie
Title: Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge()
  • Document date: 2015_8_18
  • ID: q8i2gfut_36
    Snippet: To monitor signs of pneumonia in MERS-CoV challenged animals, Xray examination was performed 1 day pre-, 1 and 3 days after MERS-CoV inoculation. Radiography revealed that all monkeys were negative for pneumonia before MERS-CoV challenge (−1 day). In mock group animals, local interstitial inflammation was detected at 1 dpi, with pneumonia diffused to adjacent pulmonary lobes at 3 dpi. Pneumonia generated in the high-dose group was delayed to 3 .....
    Document: To monitor signs of pneumonia in MERS-CoV challenged animals, Xray examination was performed 1 day pre-, 1 and 3 days after MERS-CoV inoculation. Radiography revealed that all monkeys were negative for pneumonia before MERS-CoV challenge (−1 day). In mock group animals, local interstitial inflammation was detected at 1 dpi, with pneumonia diffused to adjacent pulmonary lobes at 3 dpi. Pneumonia generated in the high-dose group was delayed to 3 dpi, with infiltration confined to a single lobe (Fig. 3a) . Although pneumonia was detected in low-dose monkeys at 1 dpi, infiltration and interstitial inflammation was less severe compared with the mock group.

    Search related documents:
    Co phrase search for related documents
    • challenge animal and high dose: 1, 2, 3
    • challenge animal and low dose: 1
    • challenge animal and MERS cov: 1, 2, 3, 4, 5
    • challenge animal and MERS CoV challenge: 1, 2, 3
    • day MERS CoV challenge and high dose: 1
    • day MERS CoV challenge and low dose: 1
    • day MERS CoV challenge and MERS cov: 1, 2
    • day MERS CoV challenge and MERS CoV challenge: 1, 2
    • day MERS CoV challenge and mock group: 1
    • group animal and high dose: 1, 2
    • group animal and high dose group: 1
    • group animal and interstitial inflammation: 1
    • group animal and low dose: 1, 2
    • group animal and MERS cov: 1, 2, 3
    • high dose and low dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high dose and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • high dose and MERS CoV challenge: 1, 2, 3, 4
    • high dose and MERS cov inoculation: 1
    • high dose and mock group: 1, 2, 3, 4, 5